Skip to main content
Premium Trial:

Request an Annual Quote

Febit Biotech, Epicentre Biotechnologies, NoAb BioDiscoveries

Febit Biotech this week launched its Geniom RT Analyzer system for sample hybridization, automated processing, and analysis.
The system is designed to be used in combination with Geniom biochips that have been synthesized on Febit’s Geniom One instrument in the customer’s lab, or purchased as Ready-to-Go Biochips directly from Febit.
The content of Geniom Ready-to-Go Biochips can be chosen from a portfolio of digital microarrays provided by Febit, or from public databases, amended or supplemented by additional genomic information specific to each customer, the company said.

Epicentre Biotechnologies last week launched its Moloney Murine Leukemia Virus Reverse Transcriptase 1st-Strand cDNA Synthesis Kit for generating full-length, first-strand cDNA from total RNA or purified polyadenylated RNA-enriched samples.
The kit features Epicentre's high activity formulation MMLV Reverse Transcriptase and 10X Reaction Buffer, which the firm claims enables the production of full-length cDNA longer than 15 kb from mRNA templates using an oligo primer.

NoAb BioDiscoveries last week launched DTEx, a microarray-based technology for profiling the effects of drugs on the expression of key proteins involved in drug disposition.
Specifically, Toronto-based NoAb is offering DTEx-ABC, a service for gene expression profiling of the human efflux drug transporters; DTEx-ADME for gene expression profiling of key human efflux and uptake drug transporters, Phase I and II metabolic enzymes, and nuclear factors; and DTEx-Custom for gene expression profiling of human genes selected by the client from the NoAb BioDiscoveries gene palette.

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.